JPWO2020179868A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020179868A5 JPWO2020179868A5 JP2021503646A JP2021503646A JPWO2020179868A5 JP WO2020179868 A5 JPWO2020179868 A5 JP WO2020179868A5 JP 2021503646 A JP2021503646 A JP 2021503646A JP 2021503646 A JP2021503646 A JP 2021503646A JP WO2020179868 A5 JPWO2020179868 A5 JP WO2020179868A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- bacteria
- antibacterial composition
- inflammation
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 claims 31
- 239000002773 nucleotide Substances 0.000 claims 19
- 125000003729 nucleotide group Chemical group 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 15
- 230000000844 anti-bacterial effect Effects 0.000 claims 12
- 230000000968 intestinal effect Effects 0.000 claims 11
- 206010061218 Inflammation Diseases 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 7
- 229940079593 drug Drugs 0.000 claims 7
- 230000000845 anti-microbial effect Effects 0.000 claims 3
- 239000004599 antimicrobial Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815101P | 2019-03-07 | 2019-03-07 | |
| US62/815,101 | 2019-03-07 | ||
| PCT/JP2020/009423 WO2020179868A1 (ja) | 2019-03-07 | 2020-03-05 | 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020179868A1 JPWO2020179868A1 (enExample) | 2020-09-10 |
| JPWO2020179868A5 true JPWO2020179868A5 (enExample) | 2023-03-10 |
| JP7488581B2 JP7488581B2 (ja) | 2024-05-22 |
Family
ID=72338206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503646A Active JP7488581B2 (ja) | 2019-03-07 | 2020-03-05 | 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20220125858A1 (enExample) |
| EP (1) | EP3957367A4 (enExample) |
| JP (1) | JP7488581B2 (enExample) |
| CN (1) | CN113573780B (enExample) |
| AU (1) | AU2020232066B2 (enExample) |
| CA (1) | CA3125323A1 (enExample) |
| TW (1) | TWI843817B (enExample) |
| WO (1) | WO2020179868A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024185738A1 (ja) * | 2023-03-07 | 2024-09-12 | 慶應義塾 | グルコン酸消費菌を有効成分とする抗菌組成物 |
| CN118146998B (zh) * | 2024-03-14 | 2024-08-27 | 广东悦创生物科技有限公司 | 一株长双歧杆菌长亚种ks1及其在制备抗衰老和助睡眠药品中的应用 |
| CN119842563B (zh) * | 2025-03-17 | 2025-06-06 | 昆明医科大学第一附属医院(云南省皮肤病医院) | 多尔氏菌emf18-06b1d及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6368586B1 (en) | 1996-01-26 | 2002-04-09 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
| JP5300772B2 (ja) | 2010-03-26 | 2013-09-25 | 森永乳業株式会社 | 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料 |
| RU2567009C2 (ru) | 2010-12-17 | 2015-10-27 | Компани Жервэ Данон | ШТАММ Lactococcus lactis ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАССТРОЙСТВА ПИЩЕВАРЕНИЯ И ЕГО ПРИМЕНЕНИЕ |
| US12285475B2 (en) | 2016-11-01 | 2025-04-29 | Keio University | Bacterium capable of inducing TH1 cells |
| EP3656389A4 (en) | 2017-07-18 | 2021-11-03 | Keio University | ANTIBACTERIAL COMPOSITION AGAINST BACTERIA INDUCING TH1 CELLS |
| EP4410954A3 (en) * | 2017-12-11 | 2025-01-15 | Vedanta Biosciences, Inc. | Compositions and methods for suppressing pathogenic organisms |
-
2020
- 2020-03-05 WO PCT/JP2020/009423 patent/WO2020179868A1/ja not_active Ceased
- 2020-03-05 EP EP20766492.1A patent/EP3957367A4/en active Pending
- 2020-03-05 JP JP2021503646A patent/JP7488581B2/ja active Active
- 2020-03-05 CN CN202080013258.9A patent/CN113573780B/zh active Active
- 2020-03-05 CA CA3125323A patent/CA3125323A1/en active Pending
- 2020-03-05 AU AU2020232066A patent/AU2020232066B2/en active Active
- 2020-03-05 US US17/436,148 patent/US20220125858A1/en not_active Abandoned
- 2020-03-06 TW TW109107438A patent/TWI843817B/zh active
-
2025
- 2025-03-03 US US19/068,953 patent/US20250249049A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11452765B2 (en) | Sequence specific antimicrobials | |
| JP2021078504A5 (enExample) | ||
| JPWO2020179868A5 (enExample) | ||
| US11135273B2 (en) | Sequence specific antimicrobials | |
| EP4484581A3 (en) | Akkermansia muciniphila eb-amdk19 strain and use thereof | |
| SA520420620B1 (ar) | أوليجونيوكليوتيد مزدوج الجديلة محدد بجين أمفيرجولين وتركيبة للوقاية من وعلاج الأمراض المرتبطة بالتليف وأمراض الجهاز التنفسي تشتمل عليه | |
| EP2494059A4 (en) | USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY | |
| JP2014518849A5 (enExample) | ||
| EP2373693A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ORAL INFECTIONS BY E. COLI | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| RU2014149351A (ru) | Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий | |
| JP2017526627A5 (enExample) | ||
| RU2013114313A (ru) | Противокариесные композиции и пробиотики/пребиотики | |
| JP2004533246A5 (enExample) | ||
| BR112021019011A2 (pt) | Bactérias ácido-láticas de kimchi lactobacillus sakei wikim0109 tendo eficácia para alívio de artrite | |
| JP2017519730A5 (enExample) | ||
| CN114340609A (zh) | 产生安全量的一氧化氮的药物组合物及其用途 | |
| CN111315886A (zh) | 重组人碱性成纤维细胞生长因子(rh-bFGF)以及包含rh-bFGF的药物组合物 | |
| Klem et al. | Bacteriophage therapy against staphylococci | |
| JP2014503469A5 (enExample) | ||
| WO2020099478A3 (en) | Angptl4 oligonucleotides influencing the regulation of the fatty acid metabolism | |
| BR112022020865A2 (pt) | Composição farmacêutica para prevenção ou tratamento de câncer compreendendo weissella cibaria wikim28 como ingrediente ativo | |
| EP4233912A3 (en) | Compositions for use as a prophylactic agent to those at risk of infection of tuberculosis, or as secondary agents for treating infected tuberculosis patients | |
| CN110049772A (zh) | 深圳柯林斯菌(Collinsella shenzhenensis)及其应用 | |
| BR112022009834A2 (pt) | Oligonucleotídeo de fita dupla ctgf-específico, constructo, nanopartículas e composições farmacêuticas para prevenir ou tratar fibrose e doenças respiratórias e formulações liofilizadas |